ArticleInternal medicine (Tokyo, Japan)2022

Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis.

Yoichi Kurosawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.